RCGHX
ETF
RCGHX
·
UNKNOWN
·
25 holdings
Quick Summary
Price History
Concentration Risk
55.86%
Top-heavy
Low risk
High risk
The top 10 holdings make up 55.86% of this ETF. A bad day for those few names drags the whole fund down with them.
Top Holdings Today
Weighted by position size
LLY
▼ -0.11%
ABBV
▲ 0.27%
ISRG
▼ -2.19%
MCK
▲ 0.45%
VRTX
▼ -1.37%
IDXX
▼ -1.86%
WST
▲ 1.24%
MTD
▼ -1.90%
COO
▼ -1.29%
TMO
▼ -2.95%
Weighted avg. of top holdings
▼ -0.78%
Sector Allocation
Healthcare
94.54%
Services
1.87%
Top 10 Holdings
55.86% of fund
LLY
Eli Lilly & Co
ABBV
AbbVie Inc
ISRG
Intuitive Surgical Inc
MCK
McKesson Corp
VRTX
Vertex Pharmaceuticals Inc
IDXX
IDEXX Laboratories Inc
WST
West Pharmaceutical Services I
MTD
Mettler-Toledo International I
COO
Cooper Cos Inc/The
TMO
Thermo Fisher Scientific Inc
Other positions
All Holdings (25)
| # | Ticker | Name | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 15.15% | 14,604 | 15.69 M |
| 2 | ABBV | AbbVie Inc | 5.57% | 25,272 | 5.77 M |
| 3 | ISRG | Intuitive Surgical Inc | 5.16% | 9,449 | 5.35 M |
| 4 | MCK | McKesson Corp | 4.63% | 5,844 | 4.79 M |
| 5 | VRTX | Vertex Pharmaceuticals Inc | 4.53% | 10,347 | 4.69 M |
| 6 | IDXX | IDEXX Laboratories Inc | 4.52% | 6,931 | 4.69 M |
| 7 | WST | West Pharmaceutical Services I | 4.23% | 15,932 | 4.38 M |
| 8 | MTD | Mettler-Toledo International I | 4.07% | 3,022 | 4.21 M |
| 9 | COO | Cooper Cos Inc/The | 4.06% | 51,335 | 4.21 M |
| 10 | TMO | Thermo Fisher Scientific Inc | 3.94% | 7,048 | 4.08 M |
Showing top 10 of 25 holdings
·
Listed: 96.41%
·
3.59% in other positions
Related ETFs
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: N/A
Profitability
ROE: N/A · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | N/A | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: N/A
Safety
D/E: N/A · Current: N/A| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | N/A |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: N/A · EV/EBITDA: N/A
Valuation
P/E: N/A · EV/EBITDA: N/A| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | N/A | Enterprise Value | N/A |
Per Share
EPS: N/A · FCF/Share: N/A
Per Share
EPS: N/A · FCF/Share: N/A| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A
Efficiency
FCF Conv: N/A · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Comparación con Pares
vs mediana del sector ETF (25157 pares)
Comparado con empresas similares en ETF
Comparación con Pares
vs mediana del sector ETF (25157 pares) Comparado con empresas similares en ETF| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | — | — |
| P/B | — | — |
| ROE % | — | — |
| Net Margin % | — | — |
| Rev Growth 5Y % | — | — |
| D/E | — | — |
{"event":"ticker_viewed","properties":{"ticker":"RCGHX","listing_kind":"etf","pathname":"/etfs/rcghx","exchange":"UNKNOWN","country":"US"}}




